Inhibition of ferroptosis via SLC25A39-NRF2 axis drives Osimertinib resistance in lung adenocarcinoma | Cellular and Molecular Life Sciences
link.springer.com/article/10.1007/s00018-026-...Posted Aug 3, 2026, 1:53 PM UTC
10
link.springer.com
Loading comments…